疑似肺炎中抗生素克制策略试验:外科感染学会多中心试点研究
这项由外科感染学会开展的多中心整群随机交叉试点试验,在4个外科与创伤ICU中比较了立即启动抗生素与标本启动抗生素两种策略,纳入186例插管、支气管镜取培养、无需血管加压药的疑似肺炎患者。标本启动组抗生素启动时间显著延迟(0 vs 9.3小时,p<0.0001),19.4%的患者完全避免了抗生素使用。两组方案依从率、30天死亡率、30天无呼吸机存活天数均无差异。作者结论为标本启动策略未导致更差的临床结局。
要点
- 在无需血管加压药的插管疑似医院获得性肺炎患者中,标本启动组抗生素启动时间显著晚于立即启动组(0 vs 9.3小时,p<0.0001)。
- 标本启动组有19.4%的患者在该次感染发作期间完全避免了抗生素使用。
- 两组方案依从率、30天死亡率、30天无呼吸机存活天数均无差异。
- 该策略适用于插管、支气管镜取培养、无需血管加压药的疑似肺炎患者,未纳入需血管加压素的患者。
适用人群与场景
- 纳入插管、疑似肺炎、经支气管镜获取培养、且不需要血管加压药的患者;94.6%为创伤患者(84.4%为钝性创伤),中位年龄50.5岁,女性占21%。
- 研究在4个外科与创伤ICU进行,每中心经过洗脱期后交叉进入另一组。
诊断标准与关键阈值
- 标本启动组:抗生素延迟至革兰染色或培养结果提示感染时才启动。
- 立即启动组:留取培养后立即启动抗生素, regardless of patient status。
处置流程与药物剂量
- 立即启动组:留取培养后立即给予抗生素,不考虑患者状态。
- 标本启动组:留取培养后暂不给抗生素,直至客观革兰染色或培养结果提示感染。
研究设计与关键结果
- 研究类型:实用性整群随机交叉试点试验;4个外科与创伤ICU;共186例患者、244份培养,仅分析首次培养;每组93例(50%)。
- 主要结局:标本启动组抗生素启动时间显著晚于立即启动组(0 vs 9.3小时,p<0.0001);19.4%的患者在该次发作中完全未使用抗生素。
- 方案依从率、30天死亡率、30天无呼吸机存活天数两组间无差异。
- 基线人口学、合并症、SOFA评分、APACHE II评分、损伤严重度评分均无差异。
证据类型、等级与局限
- 证据类型:多中心整群随机交叉试点试验;证据等级:治疗/护理管理,Level II。
- 局限:原文未报告局限性。
对床旁实践的改变
- 在插管、支气管镜取培养、无需血管加压药的疑似医院获得性肺炎患者中,采用标本启动抗生素策略未导致更差的临床结局,且部分患者可完全避免抗生素使用。
- 该策略不适用于需要血管加压药的患者;原文未报告该人群数据。
指南或共识出处
- 外科感染学会(Surgical Infection Society)多中心试点试验
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Pneumonia is the most common intensive care unit-acquired infection in the trauma and emergency general surgery population. Despite guidelines urging rapid antibiotic use, data supporting immediate antibiotic initiation in cases of suspected infection are limited. Our hypothesis was that a protocol of specimen-initiated antibiotic initiation would have similar compliance and outcomes to an immediate initiation protocol.
METHODS: We devised a pragmatic cluster-randomized crossover pilot trial. Four surgical and trauma intensive care units were randomized to either an immediate initiation or specimen-initiated antibiotic protocol for intubated patients with suspected pneumonia and bronchoscopically obtained cultures who did not require vasopressors. In the immediate initiation arm, antibiotics were started immediately after the culture regardless of patient status. In the specimen-initiated arm, antibiotics were delayed until objective Gram stain or culture results suggested infection. Each site participated in both arms after a washout period and crossover. Outcomes were protocol compliance, all-cause 30-day mortality, and ventilator-free alive days at 30 days. Standard statistical techniques were applied.
RESULTS: A total of 186 patients had 244 total cultures, of which only the first was analyzed. Ninety-three patients (50%) were enrolled in each arm, and 94.6% were trauma patients (84.4% blunt trauma). The median age was 50.5 years, and 21% of the cohort was female. There were no differences in demographics, comorbidities, sequential organ failure assessment, Acute Physiology and Chronic Health Evaluation II, or Injury Severity Scores. Antibiotics were started significantly later in the specimen-initiated arm (0 vs. 9.3 hours; p < 0.0001) with 19.4% avoiding antibiotics completely for that episode. There were no differences in the rate of protocol adherence, 30-day mortality, or ventilator-free alive days at 30 days.
CONCLUSION: In this cluster-randomized crossover trial, we found similar compliance rates between immediate and specimen-initiated antibiotic strategies. Specimen-initiated antibiotic protocol in patients with a suspected hospital-acquired pneumonia did not result in worse clinical outcomes compared with immediate initiation.
LEVEL OF EVIDENCE: Therapeutic/Care Management; Level II.
参考来源
- Guidry CA, Beyene RT, Watson CM, et al. Trial of antibiotic restraint in presumed pneumonia: A Surgical Infection Society multicenter pilot. J Trauma Acute Care Surg. 2022. PMID: 36534474. doi:10.1097/TA.0000000000003839
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。